Korlym is not the most expensive drug. While it is a costly medication, it is not the most expensive drug in the market. There are several drugs that surpass Korlym in terms of price. For instance, Lenmeldy, a gene therapy for metachromatic leukodystrophy, is priced at $4.25 million, making it the most expensive drug in the world12. Similarly, Hemgenix, a gene therapy for hemophilia B, is priced at $3.5 million14. These drugs are significantly more expensive than Korlym, which has a price range of $20,404 for a supply of 28 tablets5.
- Comparison with Lenmeldy: Lenmeldy, a gene therapy for metachromatic leukodystrophy, is priced at $4.25 million, which is significantly higher than Korlym's price12.
- Comparison with Hemgenix: Hemgenix, a gene therapy for hemophilia B, is priced at $3.5 million, which is also higher than Korlym's price14.
- Price of Korlym: The cost for Korlym 300 mg oral tablet is around $20,404 for a supply of 28 tablets, depending on the pharmacy5. This price is lower than that of Lenmeldy and Hemgenix, indicating that Korlym is not the most expensive drug.
In conclusion, while Korlym is a costly medication, it is not the most expensive drug in the market. There are other drugs that surpass it in terms of price, primarily gene therapies due to their curative potential and limited patient populations.
7/14/2024 08:17pm
